ELOX
Vanguard Group’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-20,786
| Closed | -$100K | – | 4597 |
|
2023
Q3 | $100K | Buy |
20,786
+100
| +0.5% | +$481 | ﹤0.01% | 4347 |
|
2023
Q2 | $80.5K | Hold |
20,686
| – | – | ﹤0.01% | 4408 |
|
2023
Q1 | $51.9K | Sell |
20,686
-19,727
| -49% | -$49.5K | ﹤0.01% | 4464 |
|
2022
Q4 | $73.6K | Sell |
40,413
-2,664,100
| -99% | -$4.85M | ﹤0.01% | 4417 |
|
2022
Q3 | $459K | Sell |
2,704,513
-117,680
| -4% | -$20K | ﹤0.01% | 4241 |
|
2022
Q2 | $762K | Hold |
2,822,193
| – | – | ﹤0.01% | 4173 |
|
2022
Q1 | $1.58M | Sell |
2,822,193
-215,296
| -7% | -$121K | ﹤0.01% | 4054 |
|
2021
Q4 | $2.14M | Sell |
3,037,489
-9,549
| -0.3% | -$6.74K | ﹤0.01% | 4006 |
|
2021
Q3 | $4.97M | Sell |
3,047,038
-8,479
| -0.3% | -$13.8K | ﹤0.01% | 3666 |
|
2021
Q2 | $6.08M | Buy |
3,055,517
+1,862,820
| +156% | +$3.71M | ﹤0.01% | 3487 |
|
2021
Q1 | $3.96M | Buy |
1,192,697
+15,091
| +1% | +$50.1K | ﹤0.01% | 3649 |
|
2020
Q4 | $4.69M | Buy |
1,177,606
+14,041
| +1% | +$55.9K | ﹤0.01% | 3388 |
|
2020
Q3 | $3.06M | Sell |
1,163,565
-11,090
| -0.9% | -$29.2K | ﹤0.01% | 3354 |
|
2020
Q2 | $3.56M | Buy |
1,174,655
+23,953
| +2% | +$72.6K | ﹤0.01% | 3244 |
|
2020
Q1 | $2.26M | Buy |
1,150,702
+9,643
| +0.8% | +$18.9K | ﹤0.01% | 3269 |
|
2019
Q4 | $8.4M | Buy |
1,141,059
+4,696
| +0.4% | +$34.6K | ﹤0.01% | 2944 |
|
2019
Q3 | $5.14M | Buy |
1,136,363
+42,609
| +4% | +$193K | ﹤0.01% | 3131 |
|
2019
Q2 | $10.9M | Buy |
1,093,754
+86,124
| +9% | +$859K | ﹤0.01% | 2809 |
|
2019
Q1 | $11.8M | Buy |
1,007,630
+42,416
| +4% | +$495K | ﹤0.01% | 2741 |
|
2018
Q4 | $11.6M | Buy |
965,214
+108,012
| +13% | +$1.3M | ﹤0.01% | 2703 |
|
2018
Q3 | $14.6M | Buy |
857,202
+321,328
| +60% | +$5.48M | ﹤0.01% | 2739 |
|
2018
Q2 | $9.15M | Buy |
+535,874
| New | +$9.15M | ﹤0.01% | 2945 |
|